The US Bankruptcy Court approved the first amended disclosure statement of MusclePharm Corporation on August 28, 2023. The debtor had filed its first amended disclosure statement in the Court on June 19, 2023. The deadline to vote on the plan and the plan objection deadline is September 12, 2023 .

The confirmation hearing for the plan has been scheduled for September 21, 2023.